# European Society of Radiotherapy & Oncology

> organisation involved in scholarly research

**Wikidata**: [Q74540815](https://www.wikidata.org/wiki/Q74540815)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/European_Society_for_Radiotherapy_and_Oncology)  
**Source**: https://4ort.xyz/entity/european-society-of-radiotherapy-oncology

## Summary
The European Society of Radiotherapy & Oncology (ESTRO) is a non-profit research institute headquartered in Brussels that focuses on advancing radiation oncology through scholarly research and clinical practice. ESTRO operates across multiple European countries including Ireland, the Netherlands, and Belgium.

## Key Facts
- ESTRO is headquartered in the City of Brussels
- The organization operates in multiple European countries including Ireland, Netherlands, and Belgium
- ESTRO generated €4,933,200 in revenue in 2020
- The organization is a non-profit research institute
- ESTRO publishes three specialized journals: Physics and Imaging in Radiation Oncology, Clinical and Translational Radiation Oncology, and Technical Innovations & Patient Support in Radiation Oncology
- The organization's EU Transparency Register ID is 114144232470-50
- ESTRO's website is https://www.estro.org
- The organization's abbreviation is ESTRO

## FAQs
### Q: What is the primary focus of European Society of Radiotherapy & Oncology?
A: ESTRO is primarily focused on scholarly research in the field of radiation oncology, advancing both scientific knowledge and clinical practice in this medical specialty.

### Q: In which countries does European Society of Radiotherapy & Oncology operate?
A: ESTRO operates across multiple European countries, including Ireland, the Netherlands, and Belgium, with its headquarters in Brussels.

### Q: What publications does European Society of Radiotherapy & Oncology produce?
A: ESTRO publishes three specialized journals: Physics and Imaging in Radiation Oncology, Clinical and Translational Radiation Oncology, and Technical Innovations & Patient Support in Radiation Oncology.

### Q: What is the financial status of European Society of Radiotherapy & Oncology?
A: ESTRO is a non-profit organization that generated €4,933,200 in revenue in 2020, as reported in their transparency records.

## Why It Matters
The European Society of Radiotherapy & Oncology plays a crucial role in advancing cancer treatment through radiation therapy across Europe. By bringing together researchers, clinicians, and other healthcare professionals, ESTRO facilitates the exchange of knowledge and best practices in radiation oncology. This collaboration leads to improved patient outcomes through innovation in treatment techniques, radiation technology, and supportive care. As a non-profit research institute, ESTRO's work directly impacts how cancer is treated, potentially saving lives and improving quality of life for patients throughout Europe. The organization's multi-country presence ensures that advancements in radiation oncology are shared and implemented broadly, creating a more cohesive and effective approach to cancer care.

## Notable For
- ESTRO is distinguished by its publication of three specialized radiation oncology journals, covering different aspects of the field from physics to clinical applications
- The organization operates across multiple European countries, serving as a pan-European platform for radiation oncology professionals
- ESTRO maintains transparency through its EU Transparency Register, with ID 114144232470-50, demonstrating its commitment to openness in its operations and funding
- As a non-profit organization generating substantial revenue (over €4.9 million in 2020), ESTRO has significant resources to support research and education in radiation oncology

## Body
### Organization Overview
European Society of Radiotherapy & Oncology (ESTRO) is a non-profit research institute headquartered in Brussels, Belgium. The organization operates across multiple European countries, including Ireland, the Netherlands, and Belgium. ESTRO generates approximately €4.9 million in revenue annually, as evidenced by its 2020 financial records.

### Publications and Research
ESTRO is distinguished by its publication of three specialized journals:
- Physics and Imaging in Radiation Oncology
- Clinical and Translational Radiation Oncology
- Technical Innovations & Patient Support in Radiation Oncology

These journals serve as key platforms for disseminating research findings and advancements in radiation oncology.

### Governance and Transparency
As an organization participating in the EU Transparency Register, ESTRO maintains transparency with ID 114144232470-50. The organization also holds an Open Funder Registry Funder ID (100011010) and a UIA Open Yearbook Organization Website ID (1100002750), indicating its established position in the European research ecosystem.

### Professional Activities
ESTRO focuses on advancing radiation oncology through scholarly research, bringing together professionals from across Europe to share knowledge and best practices in cancer treatment using radiation therapy.

## References

1. [Source](https://www.lobbyfacts.eu/datacard/european-society-for-radiotherapy-and-oncology?rid=114144232470-50)
2. [Directory of Open Access Journals](https://www.elsevier.com/journals/physics-and-imaging-in-radiation-oncology/2405-6316/guide-for-authors)
3. [Directory of Open Access Journals](https://www.elsevier.com/journals/clinical-and-translational-radiation-oncology/2405-6308/guide-for-authors)
4. [Directory of Open Access Journals](https://www.elsevier.com/journals/technical-innovations-and-patient-support-in-radiation-oncology/2405-6324/guide-for-authors)